Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
25.40
+0.14 (0.55%)
At close: Apr 26, 2024, 4:01 PM
25.44
+0.04 (0.16%)
After-hours: Apr 26, 2024, 7:59 PM EDT

Pfizer Revenue

In the year 2023, Pfizer had annual revenue of $58.50B, a decrease of -41.70%. Revenue in the quarter ending December 31, 2023 was $14.25B, a -41.34% decrease year-over-year.

Revenue (ttm)
$58.50B
Revenue Growth
-41.70%
P/S Ratio
2.45
Revenue / Employee
$664,727
Employees
88,000
Market Cap
143.43B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202358.50B-41.83B-41.70%
Dec 31, 2022100.33B19.04B23.43%
Dec 31, 202181.29B39.64B95.16%
Dec 31, 202041.65B746.00M1.82%
Dec 31, 201940.91B80.00M0.20%
Dec 31, 201840.83B-11.72B-22.31%
Dec 31, 201752.55B-278.00M-0.53%
Dec 31, 201652.82B3.97B8.13%
Dec 31, 201548.85B-754.00M-1.52%
Dec 31, 201449.61B-1.98B-3.84%
Dec 31, 201351.58B-3.07B-5.62%
Dec 31, 201254.66B-6.38B-10.45%
Dec 31, 201161.04B-4.13B-6.34%
Dec 31, 201065.17B15.90B32.26%
Dec 31, 200949.27B973.00M2.01%
Dec 31, 200848.30B-122.00M-0.25%
Dec 31, 200748.42B47.00M0.10%
Dec 31, 200648.37B966.00M2.04%
Dec 31, 200547.41B-1.58B-3.23%
Dec 31, 200448.99B4.25B9.50%
Dec 31, 200344.74B12.44B38.53%
Dec 31, 200232.29B3.27B11.27%
Dec 31, 200129.02B2.98B11.44%
Dec 31, 200026.05B-1.12B-4.13%
Dec 31, 199927.17B3.94B16.94%
Dec 31, 199823.23B12.18B110.14%
Dec 31, 199711.06B1.19B12.07%
Dec 31, 19969.86B-157.00M-1.57%
Dec 31, 199510.02B2.04B25.62%
Dec 31, 19947.98B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Elevance Health 171.75B
Sanofi 51.60B
Novartis AG 49.92B
Thermo Fisher 42.86B
Abbott Laboratories 40.11B
Amgen 28.19B
Danaher 22.52B
Stryker 20.50B
Revenue Rankings